Metrogel and Sinemet drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Metrogel (metronidazole) and Sinemet (carbidopa; levodopa). Common drug interactions include bedridden among females and renal failure acute among males.

The phase IV clinical study analyzes what interactions people have when they take Metrogel and Sinemet. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Metrogel?

Metrogel has active ingredients of metronidazole. It is often used in rosacea. eHealthMe is studying from 2,819 Metrogel users. Check the latest studies of Metrogel.

What is Sinemet?

Sinemet has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 29,601 Sinemet users. Check the latest studies of Sinemet.



On Jul, 26, 2026

14 people who take Metrogel and Sinemet together, and have interactions are studied.

Metrogel and Sinemet drug interactions.

What are the common drug interactions of Metrogel and Sinemet, by gender? *:

female:

  1. Bedridden
  2. Compulsive shopping
  3. Emotional distress
  4. Headache (pain in head)
  5. Hypersexuality
  6. Libido increased (increased sexual urge to have sex)
  7. Malaise (a feeling of general discomfort or uneasiness)
  8. Nausea (feeling of having an urge to vomit)
  9. Obsessive-compulsive disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;)
  10. Pathological gambling

male:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Chorioretinopathy (collection of fluid under the retina that results in visual distortion)
  3. Malaise (a feeling of general discomfort or uneasiness)
  4. Memory impairment
  5. Prostatic specific antigen increased
  6. Renal cell carcinoma stage iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes)
  7. Renal failure (kidney dysfunction)
  8. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  9. Visual impairment
  10. Vitreous floaters (spots before the eyes)

What are the common drug interactions of Metrogel and Sinemet, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Renal failure acute (rapid kidney dysfunction)
  2. Disease progression
  3. Renal cell carcinoma stage iv (stage iv renal cell cancer have cancer that has spread to other organs, such as the lungs, liver, bones, or brain, and may have spread to lymph nodes)
  4. Renal failure (kidney dysfunction)

60+:

  1. Chorioretinopathy (collection of fluid under the retina that results in visual distortion)
  2. Bedridden
  3. Prostatic specific antigen increased
  4. Retinal detachment (a disorder of the eye in which the retina peels away from its underlying layer of support tissue)
  5. Visual impairment
  6. Vitreous floaters (spots before the eyes)
  7. Headache (pain in head)
  8. Malaise (a feeling of general discomfort or uneasiness)
  9. Nausea (feeling of having an urge to vomit)
  10. Somnolence (a state of near-sleep, a strong desire for sleep)

What are the existing conditions these people have? *

  1. Renal Cell Carcinoma (a kidney cancer): 4 people, 28.57%
  2. Nausea And Vomiting: 4 people, 28.57%
  3. Stress And Anxiety: 3 people, 21.43%
  4. Drowsiness: 3 people, 21.43%
  5. Tremor (trembling or shaking movements in one or more parts of your body): 2 people, 14.29%
  6. Blood Testosterone Decreased: 2 people, 14.29%
  7. High Blood Pressure: 2 people, 14.29%
  8. Hyperkeratosis (thickening of the outer layer of the skin): 2 people, 14.29%
  9. Hypersensitivity: 2 people, 14.29%
  10. Muscle Spasms (muscle contraction): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Metrogel and Sinemet?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Metrogel and Sinemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Metrogel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sinemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metrogel and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sinemet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on metronidazole and carbidopa; levodopa (the active ingredients of Metrogel and Sinemet, respectively), and Metrogel and Sinemet (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: